Entrust Financial’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Entrust Financial's REGN Position: Q2 2026 in Review
Entrust Financial reduced its Regeneron Pharmaceuticals (REGN) stake by 24% in Q2 2026, selling an estimated $6.13K and leaving 29 shares worth $18.1K. The position accounts for 0.01% of the portfolio, ranked #251.
Entrust Financial first reported a position in REGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $32.4K in Q4 2025. 1,330 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Entrust Financial held 29 shares of Regeneron Pharmaceuticals worth $18.1K as of Q2 2026.
- Entrust Financial sold 9 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $6.13K.
- Regeneron Pharmaceuticals made up 0.01% of Entrust Financial's portfolio in Q2 2026, its #251 holding.
- Entrust Financial first reported a position in Regeneron Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
- Entrust Financial's Regeneron Pharmaceuticals position peaked at $32.4K in Q4 2025.
- 1,330 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Entrust Financial's 13F filing for Q2 2026, filed 20 Jul 2026.